Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-273384
Filing Date
2025-11-10
Accepted
2025-11-10 08:57:20
Documents
16
Effectiveness Date
2025-11-10

Document Format Files

Seq Description Document Type Size
1 S-8 d26054ds8.htm S-8 61536
2 EX-5.1 d26054dex51.htm EX-5.1 55560
3 EX-23.1 d26054dex231.htm EX-23.1 1278
4 EX-FILING FEES d26054dexfilingfees.htm   iXBRL EX-FILING FEES 12877
5 GRAPHIC g26054g28h30.jpg GRAPHIC 3131
6 GRAPHIC g26054g51t46.jpg GRAPHIC 4792
  Complete submission text file 0001193125-25-273384.txt   263406

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT d26054dexfilingfees_htm.xml XML 5250
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-291408 | Film No.: 251464652
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)